Order Article Reprints

Zech HB, Schafhausen P, Ramke L, Velthaus J-L, Kreutzfeldt S, Hübschmann D, Rothkamm K, Bokemeyer C, Hoffmann AS, Fröhling S, et al. Last Resort? Rationale for Comprehensive Molecular Analysis in Treatment-Refractory R/M HNSCC: A Case Report of Remarkable Response to Sacituzumab Govitecan Following Molecular and Functional Characterization. Biomedicines. 2025; 13(5):1266. https://doi.org/10.3390/biomedicines13051266

Zech, Henrike Barbara, Philippe Schafhausen, Leonie Ramke, Janna-Lisa Velthaus, Simon Kreutzfeldt, Daniel Hübschmann, Kai Rothkamm, Carsten Bokemeyer, Anna Sophie Hoffmann, Stefan Fröhling, and et al. 2025. "Last Resort? Rationale for Comprehensive Molecular Analysis in Treatment-Refractory R/M HNSCC: A Case Report of Remarkable Response to Sacituzumab Govitecan Following Molecular and Functional Characterization" Biomedicines 13, no. 5: 1266. https://doi.org/10.3390/biomedicines13051266

Zech, H. B., Schafhausen, P., Ramke, L., Velthaus, J.-L., Kreutzfeldt, S., Hübschmann, D., Rothkamm, K., Bokemeyer, C., Hoffmann, A. S., Fröhling, S., Glimm, H., Betz, C. S., Kriegs, M., & Christopeit, M. (2025). Last Resort? Rationale for Comprehensive Molecular Analysis in Treatment-Refractory R/M HNSCC: A Case Report of Remarkable Response to Sacituzumab Govitecan Following Molecular and Functional Characterization. Biomedicines, 13(5), 1266. https://doi.org/10.3390/biomedicines13051266